Discover the companies that will embark on the French Tech Tour China 2020
From November 23rd to December 4th, 2020, 8 French startups and SMEs will participate to the French Tech Tour China 2020 developed by Business France and Bpifrance.
With 877 million web users and 1.4 billion consumers, China represents an attractive market, especially for the digital industry.
With the French Tech Tour China, the 8 companies will be able to confirm their commercial interest towards the Chinese market and define their development strategies on the local market. This accelerator program enables companies to develop their network and their business flow in China. This unique immersion program helps companies to learn more about the Chinese market and to foresee international development opportunities.
The 8 winners of this 9th edition are : Aidaxis, Genesink, Geoflex, Innowtech, Qiova, Safety Line, Tallano and Transiteo. They all belong to software, digital, web, telecommunications, audiovisual, IoT-M2M, design and manufacturing of electronic equipment industries. They were chosen by a jury of French and Chinese experts including industrial players, investors and experts in coaching French businesses in China.
The laureates’ journey started on September 23rd with the usual « bootcamp », partially online this year. During this bootcamp they addressed different topics surrounding the Chinese environment, industrial property, human resources, legal and tax issues, but also communication tools specific to the Chinese market and local business culture.
Later during the program, the companies will test the viability of their development strategy. They will develop their network and meet prospects from the main Chinese ecosystems : Shenzhen/Guangzhou, Hong-Kong or Chengdu, Shanghai and Beijing. The program also offers them the opportunity to be followed by peers and mentors and to be more visible on the Chinese market.
International development is key for French companies, and Bpifrance and Business France will continue supporting them.